![Jason Aryeh](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jason Aryeh
Directeur/Membre du Conseil chez
ORCHESTRA BIOMED HOLDINGS, INC.
Fortune : 30 M $ au 31/08/2026
Profil
Mr. Jason M.
Aryeh is an Independent Director at Lifecore Biomedical, Inc., an Independent Non-Executive Director at Orchestra Biomed Holdings, Inc., an Independent Director at Anebulo Pharmaceuticals, Inc., an Independent Director at Ligand Pharmaceuticals, Inc., a Founder & Managing General Partner at JALAA Equities LP and a Member at Omicron Delta Epsilon.
He is on the Board of Directors at Lifecore Biomedical, Inc., Orchestra Biomed Holdings, Inc., Cytovia Therapeutics, Inc., Anebulo Pharmaceuticals, Inc., Orchestra BioMed, Inc., Ligand Pharmaceuticals, Inc. and Cytovia, Inc. (Massachusetts).
Mr. Aryeh was previously employed as a Vice Chairman by Immunomedics, Inc., an Independent Director by Aralez Pharmaceuticals, Inc., a Chairman by QLT, Inc., a Chairman by Novelion Therapeutics, Inc., an Independent Director by Myrexis, Inc., a Chairman by Rio Grande Renewables LLC, and an Independent Director by Nabi Biopharmaceuticals.
He also served on the board at Cystic Fibrosis Foundation Therapeutics, Inc. and CorMatrix Cardiovascular, Inc. He received his undergraduate degree from Colgate University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/06/2026 | 102 580 ( 0,51 % ) | 29 M $ | 31/08/2026 | |
| 18/05/2026 | 118 118 ( 0,22 % ) | 595 315 $ | 31/08/2026 | |
| 04/06/2026 | 69 967 ( 0,18 % ) | 312 053 $ | 31/08/2026 | |
| 26/09/2025 | 0 ( -.--% ) | - $ | 31/07/2026 |
Postes actifs de Jason Aryeh
| Sociétés | Poste | Début |
|---|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Directeur/Membre du Conseil | 27/09/2006 |
| ANEBULO PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/03/2021 |
| ORCHESTRA BIOMED HOLDINGS, INC. | Directeur/Membre du Conseil | 26/01/2023 |
| LIFECORE BIOMEDICAL, INC. | Directeur/Membre du Conseil | 01/08/2024 |
JALAA Equities LP
 JALAA Equities LP Investment ManagersFinance Profile Unavailable. | Directeur Général | 01/01/1997 |
Cytovia Holdings, Inc.
 Cytovia Holdings, Inc. Pharmaceuticals: MajorHealth Technology Engages on developing therapies to address unmet medical needs in oncology | Directeur/Membre du Conseil | - |
Cytovia Therapeutics, Inc.
 Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies for cancer and infectious diseases | Directeur/Membre du Conseil | 13/05/2021 |
Orchestra BioMed, Inc.
 Orchestra BioMed, Inc. Medical SpecialtiesHealth Technology Develops transformative therapeutic products | Directeur/Membre du Conseil | 01/11/2018 |
Omicron Delta Epsilon
 Omicron Delta Epsilon Miscellaneous Commercial ServicesCommercial Services Operates as an economic honor society | Corporate Officer/Principal | - |
Anciens postes connus de Jason Aryeh
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Jason Aryeh
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
56
Relations au 1er degré
19
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 19 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Ligand Pharmaceuticals, Inc.
 Ligand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and sells drug development technologies | Health Technology |
Lifecore Biomedical, Inc.
 Lifecore Biomedical, Inc. Pharmaceuticals: MajorHealth Technology Develops and sells sterile injectable pharmaceutical products | Health Technology |
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets ocular products | Commercial Services |
Nabi Biopharmaceuticals
 Nabi Biopharmaceuticals BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
CorMatrix Cardiovascular, Inc.
 CorMatrix Cardiovascular, Inc. Medical SpecialtiesHealth Technology Develops and markets cardiology medical devices | Health Technology |
Myrexis, Inc.
 Myrexis, Inc. Financial ConglomeratesFinance Engages in identifying, evaluating and making financial investments in life sciences assets | Finance |
JALAA Equities LP
JALAA Equities LP Investment ManagersFinance Profile Unavailable. | Finance |
Colgate University
 Colgate University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cystic Fibrosis Foundation Therapeutics, Inc.
 Cystic Fibrosis Foundation Therapeutics, Inc. BiotechnologyHealth Technology Engages in drug discovery and development | Health Technology |
Omicron Delta Epsilon
Omicron Delta Epsilon Miscellaneous Commercial ServicesCommercial Services Operates as an economic honor society | Commercial Services |
Old API Wind-down Ltd.
 Old API Wind-down Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Novelion Therapeutics, Inc.
 Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets rare disease products, metreleptin and lomitapide | Health Technology |
Orchestra BioMed, Inc.
Orchestra BioMed, Inc. Medical SpecialtiesHealth Technology Develops transformative therapeutic products | Health Technology |
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies for cancer and infectious diseases | Health Technology |
Anebulo Pharmaceuticals, Inc.
 Anebulo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Rio Grande Renewables LLC
 Rio Grande Renewables LLC Alternative Power GenerationUtilities Provides renewable energy, storage and management solutions to commercial, industrial and government clients | Utilities |
Orchestra Biomed Holdings, Inc.
 Orchestra Biomed Holdings, Inc. Medical SpecialtiesHealth Technology Manufactures therapeutic devices and solutions for treatment of hypertension in cardiac patients | Health Technology |
Cytovia Holdings, Inc.
Cytovia Holdings, Inc. Pharmaceuticals: MajorHealth Technology Engages on developing therapies to address unmet medical needs in oncology | Health Technology |
